SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Parenteral Drugs informs about unaudited financial results

12 Feb 2020 Evaluate

Pursant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Parenteral Drugs has informed that the company has attached Unaudited Financial Results (on both Standalone and Consolidated basis) for the quarter ended 31st December, 2019.

The above information is a part of company’s filings submitted to BSE.

Parenteral Drugs Share Price

3.39 0.00 (0.00%)
21-Aug-2023 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.50
Dr. Reddys Lab 1294.15
Cipla 1321.15
Zydus Lifesciences 948.00
Lupin 2275.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×